The new product line aims to provide advanced solutions that enhance surgical precision and patient safety

Meril, a global leader in medical devices and technology, has launched its latest range of surgical products portfolio for cardiovascular procedures, reinforcing its commitment to innovation and clinical excellence. The new product line aims to provide advanced solutions that enhance surgical precision and patient safety.

Here are the features and benefits of the newer cardiovascular portfolio:

• Dafodil neo: The Dafodil Neo Pericardial Bioprosthesis is a biomechanically engineered valve with enhanced implantability, optimised hemodynamics, and advanced tissue matching, offering a unique solution for both aortic and mitral valve replacement.
• Miltonia valve: The MILTONIA Bi-Leaflet Mechanical Heart Valve features durable Pyrolytic Carbon with Silicon alloying for thromboresistance and wear resistance, an open pivot design for passive washing, and a titanium-reinforced sewing cuff for precise implantation in aortic and mitral positions.
• Filaprop: A blue polypropylene suture designed for high visibility during stitching, minimising memory effect for smoother application.
• Mericron XL: A braided polyester suture featuring oval-shaped pledgets to reduce tissue damage, ensuring enhanced tissue protection.
• Meristeel: A stainless-steel monofilament suture available in various sizes, offering strength and reliability for different surgical needs.

Advanced Cardiac Suture Needles by Meril:

• Hemovas Needles: Specially designed to minimize blood loss during blood vessel extraction, enhancing surgical precision.
• V-Black Needles: Equipped with tissue and plexiglass penetrators, offering precise tissue penetration and reduced trauma.
• C2 Calcified Coronary Needles: Engineered for improved penetration in calcified vessels, minimizing tissue damage and ensuring optimal results during coronary procedures.

Meril’s CEO Vivek Shah claimed, “At Meril, we collaborate with surgical practitioners to address unmet surgical needs. This endeavour exemplifies our commitment towards the development of innovative medical instruments.”